JCU Australia logo

Subject Search

Try new Subject Search!

We've released the new Subject Search, designed to be simpler and faster than the application below.

PC3301 - Integrated Therapeutics 2

Credit points: 6
Year: 2021
Student Contribution Band: Band 2
Administered by: College of Medicine & Dentistry

Cardiovascular, renal, endocrine and gastrointestinal disease are major causes of morbidity and mortality in the Australian population. Multiple factors contribute to a person's overall cardiovascular risk including nutrition, metabolism and other medical conditions such as hypertension, dyslipidaemia, renal disease and diabetes. Lifestyle factors such as physical inactivity, obesity and smoking also play a role. Diabetes is a particularly important disease amongst this group, as it can lead to the failure of multiple organ systems, and has been increasing in Australia, particularly amongst Indigenous Australians and Torres Strait Islanders. This subject also introduces common conditions that affect the gastrointestinal and hepatobiliary systems and will describe the pathophysiology of these conditions and their clinical management. The subject will also explore the principles of nutrition in adults and children including the supply of supplementary feeding such as enteral nutrition (EN) or total parenteral nutrition (TPN). Students will demonstrate an understanding of the complex pathophysiological origins of these diseases and how these diseases inter-relate and affect each other to develop foundational competence in the management of patients with multiple co-morbidities relating to these systems

Learning Outcomes

  • Describe the pathophysiology and clinical presentation of common cardiovascular, metabolic, renal, gastrointestinal and hepatobiliary diseases relevant to pharmacy practice;
  • Effectively apply relevant clinical guidelines to the management of patients with cardiovascular, renal, endocrine (diabetes) and gastrointestinal disease;
  • Develop, propose and evaluate pharmacological treatment plans for patients with common cardiovascular, metabolic, renal, gastrointestinal and hepatobiliary diseases;
  • Demonstrate appropriate screening, communication and clinical skills necessary for the prevention, identification, and management of these conditions including non-drug and dietary interventions;
  • Explain the relationship between the pharmacology of drugs used to manage diseases in this subject and the pathophysiology of those diseases.

Subject Assessment

  • Written > Test/Quiz 1 - (10%) - Individual
  • Oral > Presentation 1 - (20%) - Individual
  • Written > Case report 1 - (40%) - Individual
  • Performance/Practice/Product > Objective structured clinical examination (OSCE) - (20%) - Individual
  • Written > Test/Quiz 2 - (10%) - Individual.
Students will be expected to have completed all core level 1 and 2 subjects.


Townsville, Study Period 1, Internal
Census Date 25-Mar-2021
Coordinator: Assoc. Professor John Smithson
Lecturers: Ms Kathy Thomas, Professor Beverley Glass, Dr Margaret Jordan, Assoc. Professor Peta-Ann Teague, Assoc. Professor John Smithson, Mr Shane MacDonald, Mrs Amanda Mackay, Ms Cassie Lanskey, Dr Robi Islam.
Workload expectations:

The student workload for this 6 credit point subject is approximately 260 hours.

  • 12 hours lectures (didactic or interactive)
  • 48 hours - Guided Learning Sessions
  • 60 hours pre-recorded content/lectures
  • assessment and self-directed study

Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.